Menu
GWAS Study

Predicted loss and gain of function mutations in ACO1 are associated with erythropoiesis.

Oskarsson GR, Oddsson A, Magnusson MK et al.

32327693 PubMed ID
GWAS Study Type
684122 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

OG
Oskarsson GR
OA
Oddsson A
MM
Magnusson MK
KR
Kristjansson RP
HG
Halldorsson GH
FE
Ferkingstad E
ZF
Zink F
HA
Helgadottir A
IE
Ivarsdottir EV
AG
Arnadottir GA
JB
Jensson BO
KH
Katrinardottir H
SG
Sveinbjornsson G
KA
Kristinsdottir AM
LA
Lee AL
SJ
Saemundsdottir J
SL
Stefansdottir L
SJ
Sigurdsson JK
DO
Davidsson OB
BS
Benonisdottir S
JA
Jonasdottir A
JA
Jonasdottir A
JS
Jonsson S
GR
Gudmundsson RL
AF
Asselbergs FW
TV
Tragante V
GB
Gunnarsson B
MG
Masson G
TG
Thorleifsson G
RT
Rafnar T
HH
Holm H
OI
Olafsson I
OP
Onundarson PT
GD
Gudbjartsson DF
NG
Norddahl GL
TU
Thorsteinsdottir U
SP
Sulem P
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Hemoglobin is the essential oxygen-carrying molecule in humans and is regulated by cellular iron and oxygen sensing mechanisms. To search for novel variants associated with hemoglobin concentration, we performed genome-wide association studies of hemoglobin concentration using a combined set of 684,122 individuals from Iceland and the UK. Notably, we found seven novel variants, six rare coding and one common, at the ACO1 locus associating with either decreased or increased hemoglobin concentration. Of these variants, the missense Cys506Ser and the stop-gained Lys334Ter mutations are specific to eight and ten generation pedigrees, respectively, and have the two largest effects in the study (EffectCys506Ser = -1.61 SD, CI95 = [-1.98, -1.35]; EffectLys334Ter = 0.63 SD, CI95 = [0.36, 0.91]). We also find Cys506Ser to associate with increased risk of persistent anemia (OR = 17.1, P = 2 × 10-14). The strong bidirectional effects seen in this study implicate ACO1, a known iron sensing molecule, as a major homeostatic regulator of hemoglobin concentration.

684,122 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

684122
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Iceland, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.